nizwaside

anticancer cpd from the sap of Desmidorchis flava; structure in first source

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

1.	Abbas, Ghulam: 2 articles (01/2016 - 12/2015)
2.	Al-Broumi, Mohammed Abdullah: 2 articles (01/2016 - 12/2015)
3.	Al-Harrasi, Ahmed: 2 articles (01/2016 - 12/2015)
4.	Al-Rawahi, Ahmed: 2 articles (01/2016 - 12/2015)
5.	Csuk, René: 2 articles (01/2016 - 12/2015)
6.	Elyassi, Ali: 2 articles (01/2016 - 12/2015)
7.	Green, Ivan R: 2 articles (01/2016 - 12/2015)
8.	Hussain, Hidayat: 2 articles (01/2016 - 12/2015)
9.	Khan, Husain Yar: 2 articles (01/2016 - 12/2015)
10.	Mahmood, Talat: 2 articles (01/2016 - 12/2015)

1.	Neoplasms (Cancer) 01/01/2016 - "Furthermore, the activity of compound 2 against cancer as well as normal epithelial cells was found to be similar to that of a previously reported pregnane glycoside, nizwaside (3). "
2.	Breast Neoplasms (Breast Cancer) 12/01/2015 - "Interestingly, nizwaside showed significant anti-proliferative effects on MDA MB231 breast cancer cells with an IC(50) of 23.5 µg/ml. Moreover, nizwaside was more effective than Doxorubicin, a well-known clinical anticancer drug, in suppressing MDA MB231 cell proliferation even at concentrations lower than that of Doxorubicin (75 µg/ml nizwaside vs. 100 µg/ml Doxorubicin). "